The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine
- PMID: 9403287
- DOI: 10.1007/s002280050353
The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine
Abstract
Methods: Codeine (50 mg) was administered to 12 extensive metabolisers (EM) and 12 poor metabolisers (PM) of debrisoquine. The oro-caecal transit time was estimated by the hydrogen breath test. The urinary excretion of codeine and metabolites during a 6-h interval was estimated after simultaneous analysis of codeine, morphine-3-glucuronide (M3G), morphine-6-glucuronide (M6G), morphine (M), normorphine (NM), norcodeine, norcodeine glucuronide and codeine-6-glucuronide using HPLC.
Results: The mean transit times after placebo were 1.3 h in the EM and 1.4 h in the PM. The corresponding figures after ingestion of codeine were 2.2 h and 2.1 h. The differences between the groups were statistically and clinically insignificant. The effect of codeine compared with placebo was significantly different in both groups. As expected, the metabolites of the O-demethylation pathway, M, M6G, M3G and NM were significantly lower in the PM. Interestingly, the recovery of the dose in the form of codeine (> 1.7 times) and norcodeine (> 2.5 times) was significantly higher in the PM, indicating compensatory metabolism via N-demethylation.
Conclusion: In contrast to the analgesic effect, the prolongation of gastrointestinal transit caused by the drug does not depend on the formation of O-demethylated active metabolites M, M6G or NM.
Similar articles
-
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.Br J Clin Pharmacol. 1989 Dec;28(6):639-45. doi: 10.1111/j.1365-2125.1989.tb03556.x. Br J Clin Pharmacol. 1989. PMID: 2611086 Free PMC article.
-
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.Br J Clin Pharmacol. 1991 Jun;31(6):635-42. doi: 10.1111/j.1365-2125.1991.tb05585.x. Br J Clin Pharmacol. 1991. PMID: 1867957 Free PMC article.
-
On the assessment of drug metabolism by assays of codeine and its main metabolites.Ther Drug Monit. 2000 Jun;22(3):258-65. doi: 10.1097/00007691-200006000-00005. Ther Drug Monit. 2000. PMID: 10850391
-
Codeine analgesia is due to codeine-6-glucuronide, not morphine.Int J Clin Pract. 2000 Jul-Aug;54(6):395-8. Int J Clin Pract. 2000. PMID: 11092114 Review.
-
The pharmacogenetics of codeine hypoalgesia.Pharmacogenetics. 1995 Dec;5(6):335-46. doi: 10.1097/00008571-199512000-00001. Pharmacogenetics. 1995. PMID: 8845855 Review.
Cited by
-
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.Clin Pharmacokinet. 2004;43(14):983-1013. doi: 10.2165/00003088-200443140-00003. Clin Pharmacokinet. 2004. PMID: 15530129 Review.
-
Codeine and clinical impairment in samples in which morphine is not detected.Eur J Clin Pharmacol. 2003 Apr;58(12):785-9. doi: 10.1007/s00228-003-0561-y. Epub 2003 Mar 1. Eur J Clin Pharmacol. 2003. PMID: 12698303
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials